WHO WE ARE
We are people that truly believe
in the benefits of in-vitro biosynthesis
Over a decade of experience
We are your experienced partner for industrial biocatalysis from mg to ton-scale with more than a decade of experience. Enzymicals experts offer their recognized expertise in the use of enzymatic processes for complex chemical synthesis, from initial catalyst-lead finding to process optimization and scale-up. Combining many years of experience in biotechnology with state-of-the art facilities, our company has success stories with many partners from diverse industries speeding up their developments. Our core working principles are high quality R&D, professionalism and customer satisfaction. By this we add value with tailor made enzymes, customized chemicals and individual process solutions and enable greener and safer manufacturing procedures.
Management
Prof. Dr.
Uwe Bornscheuer
Chairman of Supervisory Board
Prof. Dr. Uwe Bornscheuer holds the Chair for Biotechnology and Enzyme Catalysis at the Institute of Biochemistry at the University of Greifswald since 1999. He initiated the foundation of Enzymicals in 2009 as mentor, stakeholder and chairman of the supervisory board.
Dr.
David Liese
Chief Executive Officer
Dr. David Liese studied chemistry and has been an employee of Enzymicals since 2020. He has gained experience in the industry during his apprenticeship as lab assistant and as a PHD candidate in an innovation center of a global specialty chemical company.
Dr.
Henrike Brundiek
Head of Research and Development
Dr. Henrike Brundiek, a biotechnologist with more than a decade of experience in industrial biotechnology, specialized in enzyme development, expression and design. She has a strong professional background in management and execution of commercial research projects.
Dr.
Rainer Wardenga
Business Development
Dr. Rainer Wardenga is biologist and co-founder of Enzymicals. Until 2017, he was a member of the management board and was in charge for research and production. Since then he has been responsible for leading business development and marketing activities of the company.
Our Team
Our team is set-up to fulfill our clients’ needs for efficient biocatalytic solutions. Two equal groups work on biological and chemical topics and represent the necessary know-how in analytics, molecular biology, fermentation, biocatalysis, and process chemistry. Enzymicals places a clear focus on research and development, which is reflected in a quota of approx. 60% scientists in the total number of now around 20 employees.
Enzymicals – Facts
0123456789001234567890 % e a c h
well-adjusted equal proportion among biologists and chemists
012345678900123456789001234567890 s q m
lab space with dedicated areas for R&D and production of kg’s
0123456789001234567890 c o u n t r i e s
we have truly international patronage, having worked with many partners in a variety of states worldwide
0123456789001234567890 %
balanced ratio between scientists, engineers and technicians
We are eager to accomplish more.
Location
The Life Science Center Greifswald has areas of laboratory and office space as well as a training and conference area. Enzymicals currently rents a separate biosafety level 1 zone of 600 m² with dedicated areas for analytics, routine tasks, screenings, process R&D, scale-up, downstream and a kg-lab.
Network
Value proposition:
Under the framework of the Enzyme Technology Alliance the independent partners jointly tackle complex development projects spanning from in-silico catalyst discovery over AI-supported enzyme engineering to biocatalyst immobilization, DOE-based process intensification and scale-up of both enzyme production and the chemo-enzymatic process. Like interlocking pieces of a puzzle, the strengths of each member are combined not only to create a new point of contact for the biotech industry, but offer competitive solutions for both superior proteins and chemical entities.